John Glaspy

12PUBLICATIONS
63CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 27, 2024
Racial/Ethnic Disparities in Oncology Clinical Trial Participation: Investigator Attitudes, Needs, and Motivation to Improve.

Natalie P Bransky, Anne M Walling, Alexandra M Klomhaus

|Oct 10, 2024
Creating a Learning Health System in a Cancer Center: Generalizability of an Electronic Health Record Phenotype for Advanced Solid Cancer.

Anne M Walling, Karl A Lorenz, Anita Yuan

|Jun 17, 2024
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Moshe Mittelman, David H Henry, John A Glaspy

|Oct 03, 2023
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers.

Neil A O'Brien, Martina S J McDermott, Jun Zhang

|Aug 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.

Vina P Nguyen, Katie M Campbell, Theodore S Nowicki

|Mar 08, 2023
Preclinical Efficacy of the Antibody-Drug Conjugate CLDN6-23-ADC for the Treatment of CLDN6-Positive Solid Tumors.

Martina S J McDermott, Neil A O'Brien, Benjamin Hoffstrom

Pageof 2

Frequent Collaborators

3 joint publications

David H Henry

3 joint publications

Dennis J Slamon

3 joint publications

Neil O'Brien

2 joint publications

Jun Zhang